Log in to save to my catalogue

Progressive fibrosing interstitial lung disease: prevalence and clinical outcome

Progressive fibrosing interstitial lung disease: prevalence and clinical outcome

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d201f08ad0a2424cb3e5efb94afeffdd

Progressive fibrosing interstitial lung disease: prevalence and clinical outcome

About this item

Full title

Progressive fibrosing interstitial lung disease: prevalence and clinical outcome

Publisher

England: BioMed Central Ltd

Journal title

Respiratory research, 2021-10, Vol.22 (1), p.282-282, Article 282

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The progressive fibrosing (PF) phenotype of interstitial lung disease (ILD) is characterised by worsening respiratory symptoms, lung function, and extent of fibrosis on high-resolution computed tomography. We aimed to investigate the prevalence and clinical outcomes of PF-ILD in a real-world cohort and assess the prognostic significance of the PF-I...

Alternative Titles

Full title

Progressive fibrosing interstitial lung disease: prevalence and clinical outcome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d201f08ad0a2424cb3e5efb94afeffdd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d201f08ad0a2424cb3e5efb94afeffdd

Other Identifiers

ISSN

1465-993X,1465-9921

E-ISSN

1465-993X,1465-9921

DOI

10.1186/s12931-021-01879-6

How to access this item